R-82150
R-82150 (TIBO-R 82150) is an HIV-1 reverse transcriptase inhibitor that blocks the reverse transcription of viral RNA by binding to the non-substrate binding site of reverse transcriptase, thereby inhibiting viral replication. R-82150 does not inhibit the replication of HIV-2, other RNA viruses, and DNA viruses.
For research use only. We do not sell to patients.
- CAS No.: 126320-77-2
- Formula: C16H21N3S
- Molecular Weight:287.42
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| CEM-SS | CC50 |
79 μM
Compound: R-82150
|
Tested for the cytotoxicity against CEM-SS cells (determined by the inhibition of [3H]-thymidine uptake)
Tested for the cytotoxicity against CEM-SS cells (determined by the inhibition of [3H]-thymidine uptake)
|
10.1016/S0960-894X(01)81224-5 |
| CEM-SS | IC50 |
0.026 μM
Compound: R-82150
|
Tested for the inhibition of HIV-1 in CEM-SS cells measured using Syncytial assay
Tested for the inhibition of HIV-1 in CEM-SS cells measured using Syncytial assay
|
10.1016/S0960-894X(01)81224-5 |
| Lymphocyte | EC50 |
0.021 μg/mL
Compound: TIBO R-82150
|
Concentration required to inhibit HIV-1 induced cytopathicity in human MT-4 lymphocyte cells.
Concentration required to inhibit HIV-1 induced cytopathicity in human MT-4 lymphocyte cells.
|
[PMID: 1495006] |
| MT2 | IC50 |
0.217 μM
Compound: TIBO
|
Inhibitory concentration which prevents the spread of HIV-1 IIIB infection in MT2 T-lymphoid cells
Inhibitory concentration which prevents the spread of HIV-1 IIIB infection in MT2 T-lymphoid cells
|
[PMID: 7689109] |
| MT4 | CC50 |
>20 μg/mL
Compound: TIBO R-82150
|
Concentration required to reduce human MT-4 cell viability by 50%.
Concentration required to reduce human MT-4 cell viability by 50%.
|
[PMID: 1495006] |
| MT4 | CC50 |
>80 μM
Compound: TIBO R-82150
|
Cytotoxic concentration required to reduce MT-4 cell viability by 50%
Cytotoxic concentration required to reduce MT-4 cell viability by 50%
|
[PMID: 1501224] |
| MT4 | EC50 |
0.076 μM
Compound: TIBO R-82150
|
Concentration required to inhibit HIV-1 induced cytopathicity in MT-4 cells by 50%
Concentration required to inhibit HIV-1 induced cytopathicity in MT-4 cells by 50%
|
[PMID: 1501224] |
| MT4 | IC50 |
0.044 μM
Compound: 1
|
Effective concentration of compound required to achieve 50% protection of MT-4 cells against the cytopathic effect of HIV-1
Effective concentration of compound required to achieve 50% protection of MT-4 cells against the cytopathic effect of HIV-1
|
[PMID: 7877144] |
| MT4 | IC50 |
0.097 μM
Compound: 10a
|
Ability to block replication of HIV-1 virus in mock infected MT-4 cells
Ability to block replication of HIV-1 virus in mock infected MT-4 cells
|
[PMID: 1956037] |
| MT4 | IC50 |
0.097 μM
Compound: 1ca
|
Effective concentration of compound required to achieve 50% protection of MT-4 cells against the cytopathic effect of HIV-1 number of experiments = 7
Effective concentration of compound required to achieve 50% protection of MT-4 cells against the cytopathic effect of HIV-1 number of experiments = 7
|
[PMID: 7877143] |
| MT4 | IC50 |
28 nM
Compound: 11
|
Antiviral activity against HIV1 3B infected in MT4 cells
Antiviral activity against HIV1 3B infected in MT4 cells
|
[PMID: 22268494] |
Chemical Information
-
CAS No. 126320-77-2
-
Molecular Weight 287.42
-
Formula C16H21N3S
-
SMILES
S=C1NC2=C(N1C[C@H](C)N(C/C=C(C)\C)C3)C3=CC=C2
-
Synonyms
TIBO-R 82150
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)